Biosite makes timely UK entry into stroke care
This article was originally published in Clinica
Biosite today launched its Triage Stroke Panel in the UK, a multi-marker blood-test that promises a breakthrough in the rapid detection and assessment of stroke. It comes at a time when the condition has recently emerged as one where improvements in emergency care, particularly through early diagnosis, would result in a disproportionately great improvement in outcomes.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.